Rare diseases
Investigational molecules
Locations
Back to Germany1 444 clinical trials in Hochheim Am Main, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Juniper Berry Oil for Digestive Issues like Cramps, Gas, and Bloating in Adults
GermanyStudy on ACOU085 to Prevent Hearing Loss in Testicular Cancer Patients Receiving Cisplatin
GermanyStudy of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer
GermanyStudy of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer
GermanyStudy on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure
GermanyStudy on Spesolimab for Treating Recurrent Flares in Patients with Generalized Pustular Psoriasis
GermanyStudy on the Safety and Effects of STAR-0215 for Adults with Hereditary Angioedema
GermanyStudy on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients
GermanyStudy on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy
GermanyStudy on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression
GermanyStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Gaucher disease and Niemann-Pick disease, exploring new therapeutic approaches for these challenging genetic conditions. Studies aim to evaluate novel treatments for improving neurological symptoms and overall patient outcomes.
Clinical investigations evaluating venglustat and nizubaglustat's effectiveness in managing disease progression.
Research centered on treating Mucopolysaccharidosis Type II (Hunter Syndrome) and Pompe disease, with multiple studies investigating innovative enzyme replacement therapies and novel drug combinations.
Evaluation of treatments like JR-141 and cipaglucosidase alfa for improved patient outcomes.
Studies focused on preventing respiratory syncytial virus infections in older adults, with particular attention to vaccine development and immune response assessment.
Investigation of revaccination strategies and long-term protection against respiratory infections.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
